Nrf2-mediated neuroprotection response to recurrent hypoglycemia is insufficient to prevent cognitive impairment in a rodent model of type 1 diabetes

    Research output: Contribution to journalArticlepeer-review

    32 Citations (Scopus)
    228 Downloads (Pure)

    Abstract

    It remains uncertain whether recurrent non-severe hypoglycemia (Hypo) results in long-term cognitive impairment in type 1 diabetes (T1D). Both T1D and Hypo can compromise host defenses against oxidative stress. This study tested the hypothesis that specifically in the T1D state, Hypo leads to cognitive impairment via a pathological response to oxidative stress. Wild-type (Control) and Nuclear factor-erythroid 2 p45-related factor 2 (Nrf2) null mice were studied. Eight groups of mice (Control and Nrf2-/- ±T1D and ±Hypo) were subject to recurrent, twice-weekly, insulin or saline injections over 4 weeks, after which cognitive function was assessed and brain tissue analyzed. Recurrent moderate hypoglycemia in T1D, but not Control mice significantly impaired cognitive performance, and this was associated with hippocampal oxidative damage and inflammation despite an enhanced expression of Nrf2 and its target genes Hmox1 and Nqo1. In Nrf2-/-mice, both T1D and Hypo independently resulted in impaired cognitive performance and this was associated with oxidative cell damage and marked inflammation. Together, these data suggest that Hypo induces an Nrf2-dependent antioxidant response in the hippocampus, which counteracts oxidative damage. However, in T1D this neuroprotective mechanism is insufficient to prevent neuronal oxidative damage, resulting in chronic deficits in working and long-term memory.
    Original languageEnglish
    Pages (from-to)3151-3160
    Number of pages10
    JournalDiabetes
    Volume65
    Issue number10
    Early online date13 Jul 2016
    DOIs
    Publication statusPublished - 1 Oct 2016

    Fingerprint

    Dive into the research topics of 'Nrf2-mediated neuroprotection response to recurrent hypoglycemia is insufficient to prevent cognitive impairment in a rodent model of type 1 diabetes'. Together they form a unique fingerprint.

    Cite this